Anna Solovyeva

Harvard University

Papers

1

Total Citations

37

H-Index

1

About

Anna Solovyeva is a pioneering researcher at the intersection of soft robotics and cardiovascular medicine, whose work is redefining therapeutic approaches to heart failure. Her most-cited study, "An Intracardiac Soft Robotic Device for Augmentation of Blood Ejection from the Failing Right Ventricle" (2017), has garnered 37 citations and represents a landmark contribution to the field. In this work, Solovyeva introduced a novel, implantable soft robotic device designed to mechanically assist the failing right ventricle—a critical yet often understudied area of cardiac support. By leveraging compliant, biomimetic materials, her device augments blood ejection without the rigid constraints of traditional ventricular assist devices, offering a less invasive, more physiologically compatible solution. This innovation not only demonstrates her ability to bridge engineering principles with clinical needs but also highlights her role in advancing soft robotics from laboratory concepts to tangible medical interventions. Solovyeva’s research holds profound implications for patients with right-sided heart failure, potentially reducing reliance on transplants and improving quality of life. Her work continues to inspire interdisciplinary collaboration, positioning her as a rising leader in bio-inspired medical device design.

Research Focus

Key Achievements

1
H-Index
1
Papers
37
Total Citations
37
Avg Citations/Paper
🏆 Most Cited Paper
An Intracardiac Soft Robotic Device for Augmentation of Blood Ejection from the Failing Right Ventricle
37 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Harvard University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago